You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results
|
|---|---|
| Published in |
BMC Clinical Pharmacology, October 2009
|
| DOI | 10.1186/1472-6904-9-17 |
| Pubmed ID | |
| Authors |
James B Adams, Matthew Baral, Elizabeth Geis, Jessica Mitchell, Julie Ingram, Andrea Hensley, Irene Zappia, Sanford Newmark, Eva Gehn, Robert A Rubin, Ken Mitchell, Jeff Bradstreet, Jane El-Dahr |
| Abstract |
This study investigated the effects of oral dimercapto succinic acid (DMSA) therapy on the behavioural symptoms of children with autism spectrum disorders (ASD) ages 3-8 years. |
X Demographics
The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 18% |
| United Kingdom | 3 | 9% |
| Côte d'Ivoire | 1 | 3% |
| Canada | 1 | 3% |
| Ireland | 1 | 3% |
| Italy | 1 | 3% |
| Unknown | 20 | 61% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 30 | 91% |
| Scientists | 2 | 6% |
| Practitioners (doctors, other healthcare professionals) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 101 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 15 | 15% |
| Student > Ph. D. Student | 11 | 11% |
| Student > Bachelor | 11 | 11% |
| Researcher | 10 | 10% |
| Student > Doctoral Student | 9 | 9% |
| Other | 24 | 24% |
| Unknown | 21 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 29% |
| Psychology | 15 | 15% |
| Agricultural and Biological Sciences | 8 | 8% |
| Social Sciences | 6 | 6% |
| Nursing and Health Professions | 4 | 4% |
| Other | 14 | 14% |
| Unknown | 25 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 62. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2023.
All research outputs
#683,316
of 25,374,917 outputs
Outputs from BMC Clinical Pharmacology
#3
of 60 outputs
Outputs of similar age
#1,655
of 107,785 outputs
Outputs of similar age from BMC Clinical Pharmacology
#2
of 4 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 60 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,785 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.